Clinical and biological heterogeneity in triple-negative breast cancer reveals a non-negligible role of her2-low

HIGHLIGHTS

• who: Xiu2032e Hu from the Second Affiliated Hospital of Air Force Medical University (NoK202010-04) and in accordance with the Declaration of Helsinki. Tissue dissociation and preparation have published the research: Clinical and biological heterogeneity in triple-negative breast cancer reveals a non-negligible role of HER2-low, in the Journal: (JOURNAL) of 18/Oct/2022
• what: The authors investigated the clinical characteristics between 157 H u00ad ER2low TNBC and 94 H u00ad ER2neg TNBC patients; then, scRNA-seq was prospectively performed on 36,168 cells from three H u00ad ER2low and four H u00ad . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.